•
Sep 30, 2022

Seres Therapeutics Q3 2022 Earnings Report

Total Revenue
$3.44M
Previous year: $127M
-97.3%
EPS
-$0.49
Previous year: $0.72
-168.1%
Gross Profit
-$39.7M
Previous year: $126M
-131.6%
Cash and Equivalents
$205M
Previous year: $227M
-9.7%
Free Cash Flow
-$60.8M
Previous year: $124M
-149.2%
Total Assets
$312M
Previous year: $396M
-21.3%

Seres Therapeutics

Seres Therapeutics